apr 27, 2017 - FDA held an expert roundtable for healthcare professionals to discuss their experiences with the use of cough suppressants in children (<18 years of age), particularly opioid containing antitussive products, as well as the data available to support recommendations made by various professional societies regarding the treatment of cough in children.
Added to timeline:
Date:
apr 27, 2017
Now
~ 9 years ago